These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17018604)

  • 21. RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma.
    Dorard C; Estrada C; Barbotin C; Larcher M; Garancher A; Leloup J; Beermann F; Baccarini M; Pouponnot C; Larue L; Eychène A; Druillennec S
    Nat Commun; 2017 May; 8():15262. PubMed ID: 28497782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CRAF, a key player in lung adenocarcinomas induced by K-Ras oncogene].
    Francoz S; Dubus P
    Med Sci (Paris); 2011 Oct; 27(10):820-2. PubMed ID: 22027418
    [No Abstract]   [Full Text] [Related]  

  • 23. Constitutive activation of the ERK pathway in melanoma and skin melanocytes in Grey horses.
    Jiang L; Campagne C; Sundström E; Sousa P; Imran S; Seltenhammer M; Pielberg G; Olsson MJ; Egidy G; Andersson L; Golovko A
    BMC Cancer; 2014 Nov; 14():857. PubMed ID: 25413220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
    Arthan D; Hong SK; Park JI
    Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phorbol 12-myristate 13-acetate upregulates cyclooxygenase-2 expression in human pulmonary epithelial cells via Ras, Raf-1, ERK, and NF-kappaB, but not p38 MAPK, pathways.
    Chang MS; Chen BC; Yu MT; Sheu JR; Chen TF; Lin CH
    Cell Signal; 2005 Mar; 17(3):299-310. PubMed ID: 15567061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon.
    Marín YE; Namkoong J; Cohen-Solal K; Shin SS; Martino JJ; Oka M; Chen S
    Cell Signal; 2006 Aug; 18(8):1279-86. PubMed ID: 16305822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of BRAF(V599E) in human melanoma abrogates transformation.
    Hingorani SR; Jacobetz MA; Robertson GP; Herlyn M; Tuveson DA
    Cancer Res; 2003 Sep; 63(17):5198-202. PubMed ID: 14500344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three novel human sporadic melanoma cell lines: signaling pathways controlled by MC1R, BRAF and β-catenins.
    Zanna P; Maida I; Grieco C; Guida S; Turpin Sevilla MC; De Summa S; Tommasi S; Vena GA; Filotico R; Guida G
    J Biol Regul Homeost Agents; 2013; 27(1):131-41. PubMed ID: 23489693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-RAF and PI-3 kinase signaling protect melanoma cells from anoikis.
    Boisvert-Adamo K; Aplin AE
    Oncogene; 2006 Aug; 25(35):4848-56. PubMed ID: 16547495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic AMP (cAMP) signaling in melanocytes and melanoma.
    Rodríguez CI; Setaluri V
    Arch Biochem Biophys; 2014 Dec; 563():22-7. PubMed ID: 25017568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The genome and epigenome of malignant melanoma.
    Dahl C; Guldberg P
    APMIS; 2007 Oct; 115(10):1161-76. PubMed ID: 18042149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [It takes two RAFs to tango].
    Lavoie H; Therrien M
    Med Sci (Paris); 2010 May; 26(5):459-60. PubMed ID: 20510139
    [No Abstract]   [Full Text] [Related]  

  • 33. B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis.
    Ugurel S; Thirumaran RK; Bloethner S; Gast A; Sucker A; Mueller-Berghaus J; Rittgen W; Hemminki K; Becker JC; Kumar R; Schadendorf D
    PLoS One; 2007 Feb; 2(2):e236. PubMed ID: 17311103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PDE4D promotes FAK-mediated cell invasion in BRAF-mutated melanoma.
    Delyon J; Servy A; Laugier F; André J; Ortonne N; Battistella M; Mourah S; Bensussan A; Lebbé C; Dumaz N
    Oncogene; 2017 Jun; 36(23):3252-3262. PubMed ID: 28092671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP.
    Rodríguez CI; Castro-Pérez E; Prabhakar K; Block L; Longley BJ; Wisinski JA; Kimple ME; Setaluri V
    Mol Cancer Res; 2017 Dec; 15(12):1792-1802. PubMed ID: 28851815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-Raf and C-Raf are required for melanocyte stem cell self-maintenance.
    Valluet A; Druillennec S; Barbotin C; Dorard C; Monsoro-Burq AH; Larcher M; Pouponnot C; Baccarini M; Larue L; Eychène A
    Cell Rep; 2012 Oct; 2(4):774-80. PubMed ID: 23022482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF.
    Heidorn SJ; Milagre C; Whittaker S; Nourry A; Niculescu-Duvas I; Dhomen N; Hussain J; Reis-Filho JS; Springer CJ; Pritchard C; Marais R
    Cell; 2010 Jan; 140(2):209-21. PubMed ID: 20141835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
    Wan L; Chen M; Cao J; Dai X; Yin Q; Zhang J; Song SJ; Lu Y; Liu J; Inuzuka H; Katon JM; Berry K; Fung J; Ng C; Liu P; Song MS; Xue L; Bronson RT; Kirschner MW; Cui R; Pandolfi PP; Wei W
    Cancer Discov; 2017 Apr; 7(4):424-441. PubMed ID: 28174173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?
    Smalley KS
    Int J Cancer; 2003 May; 104(5):527-32. PubMed ID: 12594806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRAF R391W is a melanoma driver oncogene.
    Atefi M; Titz B; Tsoi J; Avramis E; Le A; Ng C; Lomova A; Lassen A; Friedman M; Chmielowski B; Ribas A; Graeber TG
    Sci Rep; 2016 Jun; 6():27454. PubMed ID: 27273450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.